Welcome to ANCI Website!Service Hotline
Mobile: 18826804895
FAX: 0769-85075898
E-mail: net01@gtggroup.com
Address: No. 11, headquarters 2 Road, Songshanhu high tech Industrial Development Zone, Dongguan City, Guangdong Province
Edit: ANCI 2026-07-14 122
Medical power supplies operating in patient-connected or patient-adjacent environments must comply with IEC 60601-1 Edition 3.2, which imposes a fundamentally different safety architecture from commercial or industrial power standards — notably, the dual Means of Patient Protection (2 MOPP) framework, leakage current limits measured in microamperes, and creepage distances that exceed IEC 62368-1 by up to 60%. This article provides a detailed technical breakdown of the isolation architecture, dielectric withstand requirements, and the engineering trade-offs between electromagnetic compatibility filtering and patient leakage current constraints.

IEC 60601-1 defines two tiers of protection for the patient-connected path. A 1 MOPP design requires a single barrier between the mains primary circuit and the applied part (the patient connection), while 2 MOPP requires two independent barriers such that the failure of any single one does not expose the patient to hazardous voltage. The practical engineering implications are substantial:
1 MOPP implementation Transformer primary-to-secondary reinforced insulation rated at 4000 VAC (1 min), creepage ≥ 2.5 mm (Pollution Degree 2) or ≥ 4.0 mm (PD3) at 250 Vrms working voltage. Triple-insulated wire (TIW) on the secondary winding can serve as the sole MOP. Suitable for BF-type applied parts where the patient is not directly connected (e.g., ultrasound system power adapter).
2 MOPP implementation Two independent means of protection. Typical implementation: (1) Transformer reinforced insulation (2 MOP in winding itself) + (2) PCB creepage ≥ 8 mm between primary and secondary traces, optocouplers with ≥ 8 mm internal creepage (medical-grade parts), and dual series Y-capacitors across the isolation barrier — each individually rated for the full working voltage. CF-type applied parts (direct cardiac contact) always require 2 MOPP plus an additional DC-DC isolation stage on the patient side.
Engineering note: The 8 mm creepage requirement for 2 MOPP fundamentally constrains power density. A standard 65 W USB-C adapter achieves approximately 10 W/in³ using a PQ2020 transformer with 5 mm creepage — the same form factor simply cannot meet 8 mm without a bespoke bobbin with extended creepage wings, reducing power density by roughly 25-30%. Power supply designers should engage medical PSU 2 MOPP transformer design and certification partners early in the concept phase.

IEC 60601-1 limits earth leakage to ≤ 500 μA under normal condition and ≤ 1000 μA under single fault condition. This limit is driven by the Y-capacitor bank between primary and earth: at 230 V / 50 Hz, each 1000 pF of Y-capacitance contributes approximately 72 μA of leakage. A typical 2 MOPP design must keep total Y-capacitance below approximately 6900 pF to stay within the 500 μA limit — this constrains the common-mode EMI filtering, which relies on Y-capacitors to shunt high-frequency noise to earth.
BF-type applied parts: Patient leakage ≤ 100 μA (normal) / ≤ 500 μA (single fault). Achievable with a single isolation barrier (1 MOPP) plus careful management of inter-winding capacitance in the transformer (Cps ≤ 20 pF typically).
CF-type applied parts: Patient leakage ≤ 10 μA (normal) / ≤ 50 μA (single fault). This 10 μA limit is the most challenging specification in medical power supply design — it effectively demands a floating secondary output with earth-referenced patient leakage paths reduced to near-zero through a secondary-side isolated DC-DC stage. The inter-winding capacitance of this additional isolation stage must be below 3 pF to maintain the 10 μA limit at the patient connection point.
Medical power supplies must simultaneously comply with IEC 60601-1-2 (EMC), which requires conducted emission limits per CISPR 11 Group 1 Class B. The conflict arises because Y-capacitors serve dual roles — suppressing common-mode EMI (EMC requirement) and contributing to patient leakage current (safety constraint). Resolution strategies include: transformer inter-winding Faraday shields to provide a low-impedance common-mode return path without adding capacitance, soft-switching topologies (LLC resonant or quasi-resonant flyback) to reduce dv/dt at the switching node and thus reduce the common-mode noise source, and PCB layout that minimizes the switching node loop area to reduce radiated coupling into the secondary. A medical PSU EMC and safety leakage joint pre-compliance test in the prototype phase identifies the Y-capacitor vs. EMI margin conflict before design freeze.
The following comparison table highlights the key dimensional differences that directly affect PCB layout and component selection:

Q1 Can a power supply certified to IEC 62368-1 be used in medical equipment?
Not directly. While IEC 62368-1 and IEC 60601-1 share some common concepts (HBSE vs. MOP framework), the patient leakage limits, creepage distances, and risk management documentation requirements under IEC 60601-1 are more stringent. A 62368-1-certified power supply would need a full re-evaluation — not merely a gap analysis — to achieve IEC 60601-1 compliance.
Q2 What is the difference between EN 60601-1 and IEC 60601-1 for the EU market?
EN 60601-1 is the European harmonized version incorporating EU-specific annexes (ZZ annexes) that link the standard to the Medical Device Regulation (MDR 2017/745). The technical content is identical to IEC 60601-1, but the EN version requires a Notified Body review under MDR — the certification is not purely manufacturer-declared under CE as some other product categories are.
Q3 Does Triple-Insulated Wire (TIW) alone satisfy 2 MOPP?
No. Under IEC 60601-1, TIW is recognized as only one Means of Protection. To achieve 2 MOPP, the second MOP must come from another source — typically the PCB's creepage distance (≥ 8 mm) and an additional isolation component (such as a medical-grade optocoupler with ≥ 8 mm internal creepage). See detailed analysis in Section 1.
Q4 How does IEC 60601-1-2 EMC testing differ from commercial EMC standards?
IEC 60601-1-2 (Edition 4.1, 2020) incorporates IEC 60601-1 risk management requirements into EMC testing — immunity test levels are determined by the device's intended use environment (professional healthcare facility vs. home healthcare) rather than a fixed level. Additionally, essential performance criteria must be defined in the risk management file and verified during immunity testing, which is absent from commercial EMC standards like EN 55032/55035.
Q5 Is UL 60601-1 equivalent to IEC 60601-1 for the US market?
ANSI/AAMI ES 60601-1 is the US national adoption of IEC 60601-1, but includes National Deviations (NDs) that reflect specific US electrical code requirements (NEC/NFPA 70), such as different branch circuit protection assumptions and specific cord/plug requirements. A product tested to IEC 60601-1 can usually achieve UL 60601-1 certification through a delta evaluation — testing only the US-specific deviations. This is a cost-effective pathway for medical PSU UL 60601-1 delta evaluation service.
This content is provided for industry communication and informational reference only and does not constitute any form of certification commitment, testing advice, or legal opinion. The certification requirements, procedures, and standards referenced herein may change as regulations evolve — please refer to the latest official announcements from the relevant authorities. Specific certification requirements, timelines, and costs must be evaluated by professional engineers based on the actual product. For inquiries, please contact us by phone.
Phone: +86 18826804895 | Email: net01@gtggroup.com | https://www.anci.com
Leave a message, certified engineers 1 to 1 technical guidance!